Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 47

1.

11C-CHO PET in optimization of target volume delineation and treatment regimens in postoperative radiotherapy for brain gliomas.

Li FM, Nie Q, Wang RM, Chang SM, Zhao WR, Zhu Q, Liang YK, Yang P, Zhang J, Jia HW, Fang HH.

Nucl Med Biol. 2012 Apr;39(3):437-42. doi: 10.1016/j.nucmedbio.2011.10.003. Epub 2011 Dec 14.

PMID:
22172386
2.

Positron emission tomography for radiation treatment planning.

Grosu AL, Piert M, Weber WA, Jeremic B, Picchio M, Schratzenstaller U, Zimmermann FB, Schwaiger M, Molls M.

Strahlenther Onkol. 2005 Aug;181(8):483-99. Review.

PMID:
16044216
3.
4.

Imaging and target volume delineation in glioma.

Whitfield GA, Kennedy SR, Djoukhadar IK, Jackson A.

Clin Oncol (R Coll Radiol). 2014 Jul;26(7):364-76. doi: 10.1016/j.clon.2014.04.026. Epub 2014 May 11. Review.

PMID:
24824451
5.

[Proton magnetic resonance spectroscopic imaging and other types of metabolic imaging for radiotherapy planning in adult and pediatric high-grade gliomas].

Laprie A.

Cancer Radiother. 2009 Oct;13(6-7):556-61. doi: 10.1016/j.canrad.2009.07.003. Epub 2009 Sep 18. Review. French.

PMID:
19766525
6.

[Use of amino acid PET in the Diagnostic and Treatment Management of cerebral gliomas].

Galldiks N, Langen KJ.

Fortschr Neurol Psychiatr. 2012 Jan;80(1):17-23. doi: 10.1055/s-0031-1281851. Epub 2011 Dec 12. Review. German.

PMID:
22161228
7.

Increasing feasibility and utility of (18)F-FDOPA PET for the management of glioma.

Bell C, Dowson N, Puttick S, Gal Y, Thomas P, Fay M, Smith J, Rose S.

Nucl Med Biol. 2015 Oct;42(10):788-95. doi: 10.1016/j.nucmedbio.2015.06.001. Epub 2015 Jun 9. Review.

PMID:
26162582
8.

Functional MRI for radiotherapy of gliomas.

Chang J, Narayana A.

Technol Cancer Res Treat. 2010 Aug;9(4):347-58. Review.

PMID:
20626201
9.

Positron emission tomography of high-grade gliomas.

Frosina G.

J Neurooncol. 2016 May;127(3):415-25. doi: 10.1007/s11060-016-2077-1. Epub 2016 Feb 20. Review.

PMID:
26897013
10.

[Neuroimaging in brain tumors].

Arbizu J, Domínguez PD, Diez-Valle R, Vigil C, García-Eulate R, Zubieta JL, Richter JA.

Rev Esp Med Nucl. 2011 Jan-Feb;30(1):47-65. doi: 10.1016/j.remn.2010.11.001. Epub 2011 Jan 5. Review. Spanish.

11.

PET and SPECT for radiation treatment planning.

Götz L, Spehl TS, Weber WA, Grosu AL.

Q J Nucl Med Mol Imaging. 2012 Apr;56(2):163-72. Review.

12.

The current status of novel PET radio-pharmaceuticals in radiotherapy treatment planning of glioma.

Marvaso G, Barone A, Amodio N, Cascini GL, Scotti V, Bianco C.

Curr Pharm Biotechnol. 2014;14(13):1099-104. Review.

PMID:
24725130
13.

Value of 11C-methionine PET in imaging brain tumours and metastases.

Glaudemans AW, Enting RH, Heesters MA, Dierckx RA, van Rheenen RW, Walenkamp AM, Slart RH.

Eur J Nucl Med Mol Imaging. 2013 Apr;40(4):615-35. doi: 10.1007/s00259-012-2295-5. Epub 2012 Dec 12. Review.

PMID:
23232505
14.

PET and SPECT studies in children with hemispheric low-grade gliomas.

Juhász C, Bosnyák E.

Childs Nerv Syst. 2016 Oct;32(10):1823-32. doi: 10.1007/s00381-016-3125-z. Epub 2016 Sep 20. Review.

15.

Brain Tumors: An Update on Clinical PET Research in Gliomas.

Herholz K.

Semin Nucl Med. 2017 Jan;47(1):5-17. doi: 10.1053/j.semnuclmed.2016.09.004. Epub 2016 Sep 27. Review.

PMID:
27987557
16.

Imaging of adult brainstem gliomas.

Purohit B, Kamli AA, Kollias SS.

Eur J Radiol. 2015 Apr;84(4):709-20. doi: 10.1016/j.ejrad.2014.12.025. Epub 2015 Jan 7. Review.

PMID:
25641008
17.

Clinical value of O-(2-[(18)F]-fluoroethyl)-L-tyrosine positron emission tomography in patients with low-grade glioma.

Rapp M, Floeth FW, Felsberg J, Steiger HJ, Sabel M, Langen KJ, Galldiks N.

Neurosurg Focus. 2013 Feb;34(2):E3. doi: 10.3171/2012.12.FOCUS12336. Review.

PMID:
23373448
18.

Non-routine Tracers for PET Imaging of High-grade Glioma.

Frosina G.

Anticancer Res. 2016 Jul;36(7):3253-60. Review.

PMID:
27354581
19.

Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas.

Albert NL, Weller M, Suchorska B, Galldiks N, Soffietti R, Kim MM, la Fougère C, Pope W, Law I, Arbizu J, Chamberlain MC, Vogelbaum M, Ellingson BM, Tonn JC.

Neuro Oncol. 2016 Sep;18(9):1199-208. doi: 10.1093/neuonc/now058. Epub 2016 Apr 21. Review.

20.

Usefulness of positron emission tomographic studies for gliomas.

Miyake K, Ogawa D, Okada M, Hatakeyama T, Tamiya T.

Neurol Med Chir (Tokyo). 2016 Jul 15;56(7):396-408. doi: 10.2176/nmc.ra.2015-0305. Epub 2016 May 31. Review.

Supplemental Content

Support Center